Vesalius is presenting its TMVr solution during the Innovators Day at EuroPCR in Paris

Dr Peter Skarsgard, Vesalius President and Chief Scientific Officer, will be presenting Vesalius TMVr solution during the Innovators Day at EuroPCR in Paris on May 19th, 2022. We believe mitral valve repair for simple or complex degenerative mitral regurgitation, historically the domain of the surgical super-specialist, will be provided with one percutaneous device during one […]

Vesalius team is attending TCT 2019 in San Francisco

September 25-29, 2019 – Moscone Convention Center, San Francisco Vesalius team is attending TCT 2019 in San Francisco. This very specialized conference is the ideal occasion to learn more about the latest therapies in interventional cardiology and connect with corporations active in this field. 

Vesalius Successful at Cascadia Venture Forum Vancouver

October 12, 2017 – VentureLabs, Vancouver. Vesalius Cardiovascular finishes in first place at the Vancouver Cascadia Venture Forum, from a field of 6 startup ventures in the Seed category, as voted by the audience of angels, VCs, entrepreneurs, and business mentors. Vesalius will now proceed to the Cascadia Summit Competition to be held in Seattle […]